Characterization of the Overlap Syndrome of Primary Biliary Cirrhosis (Pbc) and Autoimmune Hepatitis: Evidence for It Being A Hepatitic Form of Pbc in Genetically Susceptible Individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Some patients with autoimmune liver disease present with a clinical and/or histological picture showing characteristic findings of both autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC). Various names, mostly overlap syndrome, have been used to describe these cases, which have thus far not been more closely characterized. The aim of this study was the comparison of 20 patients with overlapping features to representative patients considered suffering from typical AIH or typical PBC (20 patients in each group). We found these patients to indeed show a very mixed picture of both conditions biochemically, serologically, and histologically. However, closer analysis suggested that all of these patients were primarily suffering from PBC as all of them had at least either bile duct destruction on histology or anti–M2 positive antimitochondrial antibodies (AMA). We suggest that these PBC patients because of their genetic susceptibility, evidenced by the AIH–characteristic histocompatibility leukocyte antigen (HLA) type B8, DR3, or DR4, developed a more hepatitic picture. Response to immunosuppressive therapy was excellent. We propose that the name “overlap syndrome” be abandoned for “PBC, hepatitic form.” These observations not only have pathophysiological implications, but also suggest that therapy of PBC should be guided by the degree of biochemical and histological hepatic involvement
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This combined treatment regime has been used in patients with PBC and features of AIH with high response rates [160,161,175,180].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [180]
In the citing paper
“These criteria have been met in 1% to 14.2% of PBC patients, with higher rates found in Hispanic PBC patients.(128)(129)(130)(131)(132)(133)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [128]
Citations
Cites
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Bach, N., Thung, S. N., & Schaffner, F. (1992) · Hepatology · doi:10.1002/hep.1840150403 · Cited by 500
Ursodiol for the Long-Term Treatment of Primary Biliary Cirrhosis
Poupon, R. E., Poupon, R., & Balkau, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405123301903 · Cited by 497
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
Self-citationFrequency and nature of the variant syndromes of autoimmune liver disease
Czaja, A. J. (1998) · Hepatology · doi:10.1002/hep.510280210 · Cited by 343
Michieletti, P., Wanless, I. R., Katz, A., Scheuer, P. J., Yeaman, S. J., Bassendine, M. F., Palmer, J. M., & Heathcote, E. J. (1994) · Gut · doi:10.1136/gut.35.2.260 · Cited by 236
Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
Ben-Ari, Z., Dhillon, A. P., & Sherlock, S. (1993) · Hepatology · doi:10.1002/hep.1840180103 · Cited by 218
Krawitt, E. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604043341406 · Cited by 206
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
Goodman, Z. D., McNally, P. R., Davis, D. R., & Ishak, K. G. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065530 · Cited by 178
Research works printed but not linked: 1
- Bianchi, 1994, Pathology of the Liver, 349
Cited by
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
“However, adjunction of immunosuppressive therapy was required in most patients of other cohorts to obtain a complete biochemical response [57,58].”
BackgroundHirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
“This combined treatment regime has been used in patients with PBC and features of AIH with high response rates [160,161,175,180].”
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“(445) Regimens directed at a single predominant component of the overlap syndrome are based on the premise that these syndromes are single diseases with mixed atypical clinical features rather than concurrent diseases.(446) Most reports have described combination regimens directed at both the AIH and cholestatic compo…”
BackgroundLindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
“2% of PBC patients, with higher rates found in Hispanic PBC patients.(128-133) The wide variability among studies may be due to a variety of genetic and environmental factors as well as the nonuniform collection of biochemical, serological, immunological, and histological data.”
BackgroundSerum activity of alanine aminotransferase (ALT) as an indicator of health and disease†
Kim, W. R., Flamm, S. L., Di Bisceglie, A. M., & Bodenheimer, H. C. (2008) · Hepatology · doi:10.1002/hep.22109 · Cited by 857
Krawitt, E. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050408 · Cited by 753
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., zum Büschenfelde, K.-H. M., & Lohse, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02166-8 · Cited by 636
Self-citationBoberg, K. M., Chapman, R. W., Hirschfield, G. M., Lohse, A. W., Manns, M. P., & Schrumpf, E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.002 · Cited by 555
“Treatment of PBC patients with features of AIH Several studies have demonstrated a positive response to immunosuppressive therapy in patients with overlapping features between PBC and AIH [22,61,62,73,109,111,112], but it has also been suggested that treatment solely with UDCA alone is sufficient [63].”
BackgroundResultInfluentialSelf-citationDufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2050 · Cited by 439
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Czaja, A. J., & Manns, M. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.053 · Cited by 280
Heneghan, M. A., Yeoman, A. D., Verma, S., Smith, A. D., & Longhi, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62163-1 · Cited by 277
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis
Gleeson, D., & Heneghan, M. A. (2011) · Gut · doi:10.1136/gut.2010.235259 · Cited by 275
Ma, Y., Okamoto, M., Thomas, M. G., Bogdanos, D. P., Lopes, A. R., Portmann, B., Underhill, J., Dürr, R., Mieli-Vergani, G., & Vergani, D. (2002) · Hepatology · doi:10.1053/jhep.2002.32092 · Cited by 271
Nakanuma, Y., Zen, Y., Harada, K., Sasaki, M., Nonomura, A., Uehara, T., Sano, K., Kondo, F., Fukusato, T., Tsuneyama, K., et al. (2010) · Pathology International · doi:10.1111/j.1440-1827.2009.02500.x · Cited by 224
Autoimmune hepatitis: A comprehensive review
Liberal, R., Grant, C. R., Mieli-Vergani, G., & Vergani, D. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.11.002 · Cited by 218
Chazouillères, O., Wendum, D., Serfaty, L., Rosmorduc, O., & Poupon, R. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.017 · Cited by 194
Lohse, A. W., & Mieli-Vergani, G. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.012 · Cited by 191
Self-citationAutoimmune hepatitis with incidental histologic features of bile duct injury
Czaja, A. J., & Carpenter, H. A. (2001) · Hepatology · doi:10.1053/jhep.2001.27562 · Cited by 189
Baeres, M., Herkel, J., Czaja, A. J., Wies, I., Kanzler, S., Cancado, E. L. R., Porta, G., Nishioka, M., Simon, T., Daehnrich, C., et al. (2002) · Gut · doi:10.1136/gut.51.2.259 · Cited by 184
Self-citationJoshi, S., Cauch-Dudek, K., Wanless, I. R., Lindor, K. D., Jorgensen, R., Batts, K., & Heathcote, J. E. (2002) · Hepatology · doi:10.1053/jhep.2002.30902 · Cited by 174
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis
Poupon, R., Chazouilleres, O., Corpechot, C., & Chrétien, Y. (2006) · Hepatology · doi:10.1002/hep.21229 · Cited by 170
Overlap of Autoimmune Hepatitis and Primary Biliary Cirrhosis: Long-Term Outcomes
Silveira, M. G., Talwalkar, J. A., Angulo, P., & Lindor, K. D. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01136.x · Cited by 165
“The combination of UDCA with immunosuppressive therapy, nevertheless, could potentially provide benefits among patients with PBC and definite overlap (4, 10).”
BackgroundOverlap syndromes among autoimmune liver diseases
Rust, C., & Beuers, U. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3368 · Cited by 158
Poupon, R. Y., Chazouillères, O., & Poupon, R. E. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80421-3 · Cited by 169
AL‐CHALABI, T., PORTMANN, B. C., BERNAL, W., MCFARLANE, I. G., & HENEGHAN, M. A. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03722.x · Cited by 149
Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis
O'Brien, C., Joshi, S., Feld, J. J., Guindi, M., Dienes, H. P., & Heathcote, E. J. (2008) · Hepatology · doi:10.1002/hep.22380 · Cited by 146
Self-citationKuiper, E. M. M., Zondervan, P. E., & van Buuren, H. R. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.03.004 · Cited by 152
“he diagnostic criteria for PBC are as follows: (1) serum alkaline hosphatase (ALP) level 2-fold or greater the upper limit of ormal (ULN) or serum -glutamyltransferase levels 5-fold or reater the ULN; (2) positive test for AMA; and (3) liver biopsy pecimen showing florid bile duct lesions.”
MethodAutoimmune cholangitis within the spectrum of autoimmune liver disease
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, B. S. (2000) · Hepatology · doi:10.1053/jhep.2000.7878 · Cited by 136
Talwalkar, J. A., Keach, J. C., Angulo, P., & Lindor, K. D. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05703.x · Cited by 127
“The term overlap syndrome has been primarily described in the literature among individuals with features of AIH and PBC (3, 4).”
BackgroundInfluentialThe serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome
Muratori, P., Granito, A., Pappas, G., Pendino, G. M., Quarneti, C., Cicola, R., Menichella, R., Ferri, S., Cassani, F., Bianchi, F. B., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.126 · Cited by 125
Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis
Neuhauser, M., Bjornsson, E., Treeprasertsuk, S., Enders, F., Silveira, M., Talwalkar, J., & Lindor, K. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.616 · Cited by 116
Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management
Oo, Y. H., Hübscher, S. G., & Adams, D. (2010) · Hepatology International · doi:10.1007/s12072-010-9183-5 · Cited by 130
“Overlap syndromes are classified as autoimmune liver diseases that are difficult to classify within a single diagnostic category, such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), or AIH, because they have biochemical, immunological, clinical, or histological features suggestive of more th…”
BackgroundAutoimmune liver disease: overlap and outliers
Washington, M. K. (2007) · Modern Pathology · doi:10.1038/modpathol.3800684 · Cited by 129
Cirrhosis, W. S. (. V. F. C. P. G. F. P. B. (2014) · Hepatology Research · doi:10.1111/hepr.12270 · Cited by 124
Woodward, J. M., & Neuberger, J. (2001) · Hepatology · doi:10.1053/jhep.2001.23316 · Cited by 115
Autoimmune hepatitis and its variant syndromes
BEN-ARI, Z., & CZAJA, A. J. (2001) · Gut · doi:10.1136/gut.49.4.589 · Cited by 102
Clustering and commonalities among autoimmune diseases
Mackay, I. R. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.006 · Cited by 110
Carpenter, H. A., & Czaja, A. J. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00022-3 · Cited by 102
“Autoimmune hepatitis and PBC The overlap syndrome of autoimmune hepatitis and PBC is characterized by the clinical features of autoimmune hepatitis, AMA, elevation of the serum ALT level and/or immunoglobulin M concentration, and histologic features of bile duct injury [10,15,23,25].”
BackgroundZhao, P., & Han, Y. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-1 · Cited by 96
“study showed that patients with overlap syndrome of AIH and PBC presented with typical features of PBC when compared to AIH and PBC patients [13].”
ResultWilson’s disease with superimposed autoimmune features: Report of two cases and review
Milkiewicz, P., Saksena, S., Hübscher, S. G., & Elias, E. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02158.x · Cited by 95
Lüth, S., Kanzler, S., Frenzel, C., Kasper, H. U., Dienes, H. P., Schramm, C., Galle, P. R., Herkel, J., & Lohse, A. W. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318157c614 · Cited by 93
“Although overlapping features between AIH and primary biliary cirrhosis seem to be common, overlapping disease features of AIH and PSC are increasingly reported.(3,4) A clear classification and definition of pathogenesis, prevalence, serologic profile, treatment options, and prognosis of overlap patients is lacking.”
BackgroundSelf-citationDiagnosis and Management of the Overlap Syndromes of Autoimmune Hepatitis
Czaja, A. J. (2013) · Canadian Journal of Gastroenterology · doi:10.1155/2013/198070 · Cited by 95
“The autoimmune liver diseases undoubtedly have blurred outer boundaries of diagnosis that cannot be rigidly defined, and the distinction between a hepatitic PBC and cholestatic AIH may be difficult (21,50).”
BackgroundMuratori, L., Granito, A., Muratori, P., Παππάς, Γ., & Bianchi, F. B. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.009 · Cited by 92
MURATORI, P., MURATORI, L., GERSHWIN, M. E., CZAJA, A. J., PAPPAS, G., MACCARIELLO, S., GRANITO, A., CASSANI, F., LORIA, P., LENZI, M., et al. (2003) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02332.x · Cited by 86
Fibrosis in Autoimmune and Cholestatic Liver Disease
Penz-Österreicher, M., Österreicher, C. H., & Trauner, M. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.001 · Cited by 84
“Importantly, histological features canoverlapwith those of PSC or PBC and a careful histological examination is therefore mandatory [67,68].”
BackgroundS2k Leitlinie Autoimmune Lebererkrankungen: AWMF-Reg. Nr. 021-27
Authors, Collaborators:, durch:, E. B., Deutsche Gesellschaft für Gastroenterologie, V. U. S. (. (., (DGIM), D. G. F. I. M., (DCCV), D. M. C. U. V., e.V., D. L., (DEGUM), D. G. F. U. I. D. M., (DGE-BV), D. G. F. E. U. B. V., (DGKJ), D. G. F. K. U. J., et al. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0043-120199 · Cited by 90
“[412] Lohse AW, zum Buschenfelde KH, Franz B et al.”
BackgroundHeurgué, A., Vitry, F., Diebold, M.-D., Yaziji, N., Bernard-Chabert, B., Pennaforte, J.-L., Picot, R., Louvet, H., Frémond, L., Geoffroy, P., et al. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)89323-7 · Cited by 80
Ozaslan, E., Efe, C., Heurgué–Berlot, A., Kav, T., Masi, C., Purnak, T., Muratori, L., Ustündag, Y., Bresson–Hadni, S., Thiéfin, G., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.09.021 · Cited by 79
The Overlap Syndromes of Autoimmune Hepatitis
Czaja, A. J. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2367-1 · Cited by 85
“aminotransferase levels has long been recognized as an engine for disease progression in PBC and a justification for corticosteroid therapy [45, 96–100].”
BackgroundDifficult treatment decisions in autoimmune hepatitis
Czaja, A. J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i8.934 · Cited by 78
Autoantibodies and overlap syndromes in autoimmune rheumatic disease
Jury, E. C., D’Cruz, D. P., & Morrow, W. J. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.5.340 · Cited by 74
Yang, F., Wang, Q., Wang, Z., Miao, Q., Xiao, X., Tang, R., Chen, X., Bian, Z., Zhang, H., Yang, Y., et al. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8516-5 · Cited by 71
Understanding COPD-overlap syndromes
Poh, T. Y., Aogáin, M. M., Chan, A., Yii, A. C. A., Yong, V. F. L., Tiew, P. Y., Koh, M. S., & Chotirmall, S. H. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1305895 · Cited by 76
“Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome (PBC-AIH) is an emerging field for hepatology research [2,3].”
BackgroundPortmann, B., & Zen, Y. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.03853.x · Cited by 70
Proposal of a new staging and grading system of the liver for primary biliary cirrhosis
Hiramatsu, K., Aoyama, H., Zen, Y., Aishima, S., Kitagawa, S., & Nakanuma, Y. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02537.x · Cited by 71
“PBC with evident features of interface hepatitis and lobular hepatitis is known as a hepatic form of PBC or overlapping syndrome.(3,23,27) In this sense, interface hepatitis and lobular hepatitis can be used as factors reflecting the necroinflammatory activity of a hepatic form of PBC.”
BackgroundAutoimmune overlapping syndromes
Poupon, R. Y. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00092-8 · Cited by 73
“To the author’s knowledge, five cases of consecutive PBC and AIH have been reported [61,65–67] with close to 15 cases diagnosed during the last 5 years.”
BackgroundCurrent concepts in autoimmune hepatitis
Czaja, A. J. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32081-2 · Cited by 74
Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis
Freedman, B. L., Danford, C. J., Patwardhan, V. R., & Bonder, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051449 · Cited by 79
Cholestatic phenotypes of autoimmune hepatitis
Czaja, A. J. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.08.039 · Cited by 63
“(62) The possibility of misclassification is supported by the rarity that the highly disease-specific features of PBC (florid duct lesions) and PSC (cholangiographic changes of biliary strictures and dilations) occur together.”
BackgroundInfluentialOptimizing Diagnosis From the Medical Liver Biopsy
Czaja, A. J., & Carpenter, H. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.031 · Cited by 67
Montano-Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181587d18 · Cited by 62
Gheorghe, L., Iacob, S., Gheorghe, C., Iacob, R., Simionov, I., Vadan, R., Becheanu, G., Parvulescu, I., & Toader, C. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200406000-00012 · Cited by 60
Autoantibodies in Autoimmune Liver Disease
Czaja, A. J. (2005) · Advances in clinical chemistry · doi:10.1016/s0065-2423(05)40004-9 · Cited by 62
Czaja, A. J., Shums, Z., & Norman, G. L. (2002) · Autoimmunity · doi:10.1080/0891693021000054101 · Cited by 60
Oikawa, T., Takahashi, H., Ishikawa, T., Hokari, A., Otsuki, N., Azuma, M., Zeniya, M., & Tajiri, H. (2007) · Pathology International · doi:10.1111/j.1440-1827.2007.02129.x · Cited by 61
Autoimmune hepatitis and overlap syndromes
Dienes, H. P., Erberich, H., Dries, V., Schirmacher, P., & Lohse, A. W. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00007-7 · Cited by 61
“In most cases of AIH/PBC overlap syndrome, clinical symptoms, biochemical parameters, and histopathology of both entities occur simultaneously [3,34–37].”
BackgroundSelf-citationDevelopment of autoimmune hepatitis in primary biliary cirrhosis
Gossard, A. A., & Lindor, K. D. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01538.x · Cited by 57
HLA and Autoimmune Digestive Disease: A Clinically Oriented Review for Gastroenterologists
Cassinotti, A., Birindelli, S., Clerici, M., Trabattoni, D., Lazzaroni, M., Ardizzone, S., Colombo, R., Rossi, E., & Porro, G. B. (2008) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.10 · Cited by 61
Nakanuma, Y., Zen, Y., & Portmann, B. C. (2012) · MacSween's Pathology of the Liver · doi:10.1016/b978-0-7020-3398-8.00010-6 · Cited by 56
Cappello, M., Randazzo, C., Bravatà, I., Licata, A., Peralta, S., Craxì, A., & Almasio, P. L. (2014) · Clinical Medicine Insights Gastroenterology · doi:10.4137/cgast.s13125 · Cited by 67
Zhang, W., Zhao, F.-R., Chen, J., & Chen, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092267 · Cited by 59
An unusual form of autoimmune hepatitis in young Somalian men
D'Souza, R., Sinnott, P. J., Glynn, M. J., Sabin, C. A., & Foster, G. R. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01088.x · Cited by 55
“Patients have manifestations of AIH and another type of chronic liver disease (overlap syndrome) such as primary biliary cirrhosis, primary sclerosing cholangitis, or concurrent viral infection (12, 13, 14).”
BackgroundBeuers, U. H. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.009 · Cited by 61
“Therefore, the AIH-PBC overlap of these patients was named ‘PBC, hepatitic form’ [17].”
BackgroundResultThe liver as a central "hub" of the immune system: pathophysiological implications
Ronca, V., Gerussi, A., Collins, P., Parente, A., Oo, Y. H., & Invernizzi, P. (2025) · Physiological Reviews · doi:10.1152/physrev.00004.2023 · Cited by 59
Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis
Nezu, S., Tanaka, A., Yasui, H., Imamura, M., Nakajima, H., Ishida, H., & Takahashi, S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04434.x · Cited by 52
The Hepatitic/Cholestatic "Overlap" Syndrome: An Italian Experience
Muratori, L., Cassani, F., Pappas, G., Guidi, M., Mele, L., VERONESI, L., Lenzi, M., Bianchi, F. B., & Muratori, P. (2002) · Autoimmunity · doi:10.1080/0891693021000064272 · Cited by 51
“Czaja considers these patients as variant forms of AIH,([1]) Chazouillères suggests that PBC patients with AIH features suffer from two different diseases,([4]) whereas Lohse interprets the PBC/AIH overlap syndrome as a “hepatitic form” of PBC in genetically susceptible individuals.([5]) In the pediatric”
BackgroundObeticholic acid and budesonide for the treatment of primary biliary cirrhosis
Silveira, M. G., & Lindor, K. D. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.873404 · Cited by 53
“A few small case series describe complete biochemical response of most or all patients to the combination of UDCA and corticosteroids [68-72], including budesonide 3 mg twice or three times daily [73], either as first-line therapy in PBC--AIH overlap or after failure to respond to treatment for PBC or AIH alone.”
BackgroundYokokawa, J., Saito, H., Kanno, Y., Honma, F., Monoe, K., Sakamoto, N., Abe, K., Takahashi, A., Yokokawa, H., & Ohira, H. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06018.x · Cited by 45
Neuberger, J., & Bradwell, A. R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00322-7 · Cited by 45
A Spectrum of Histopathologic Findings in Autoimmune Liver Disease
Terracciano, L., Patzina, R. A., Lehmann, F. S., Tornillo, L., Cathomas, G., Mhawech, P., Vecchione, R., & Bianchi, L. (2000) · American Journal of Clinical Pathology · doi:10.1309/bhym-hmy5-vm1p-7geg · Cited by 43
Tan, C., & Ho, J. M. S. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23792 · Cited by 44
Farias, A. Q., Gonçalves, L. L., Bittencourt, P. L., De Melo, E. S., Abrantes‐Lemos, C. P., Porta, G., Nakhle, M. C., Carrilho, F. J., & Cancado, E. L. R. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04130.x · Cited by 43
Yamamoto, K., Terada, R., Okamoto, R., Hiasa, Y., Abe, M., Onji, M., & Tsuji, T. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300006 · Cited by 47
SUZUKI, Y., ARASE, Y., IKEDA, K., SAITOH, S., TSUBOTA, A., SUZUKI, F., KOBAYASHI, M., AKUTA, N., SOMEYA, T., MIYAKAWA, Y., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03372.x · Cited by 40
Dellavance, A., Júnior, A. G., Cintra, A. F. U., Ximenes, A. C., Nuccitelli, B., Taliberti, B. H., Moreira, C., von Mühlen, C. A., Bichara, C. D. A., dos Santos, C. H. R., et al. (2003) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042003000300002 · Cited by 40
“Doi((15)), Fabiana Nunes de Carvalho Guimarães((16)), Flávia Ikeda e Araújo((17)), Hugo Mendonça Mundim((18)), Jozelia Rego((19)), Lisiane Ericonio dos Anjos Vieira((20)), Luciana Poli((21)), Luís Eduardo Coelho Andrade((22)), Maria Roseli Callado((23)), Mauro Meira Mesquita ((24)), Mitiko Sugiyama((25)), Natasha Slhe…”
BackgroundOverlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis
To, U. K., & Silveira, M. G. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.03.010 · Cited by 43
De novo autoimmune hepatitis –is this different in adults compared to children?
Kerkar, N. N., & Vergani, D. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.023 · Cited by 39
Primary biliary cirrhosis and other ductopenic diseases
Burt, A. D. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00010-7 · Cited by 39
Overlap Syndromes of Cholestatic Liver Diseases and Auto-Immune Hepatitis
Schramm, C., & Lohse, A. W. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:105 · Cited by 37
Self-citationAUTOANTIBODIES BY LINE IMMUNOASSAY IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
Saito, H., Takahashi, A., Abe, K., Okai, K., Katsushima, F., Monoe, K., Kanno, Y., & Ohira, H. (2012) · FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · doi:10.5387/fms.58.107 · Cited by 39
Update on autoimmune hepatitis
Teufel, A., Galle, P. R., & Kanzler, S. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1035 · Cited by 46
“. In these patients, an overlap syndrome of AIH and PBC should be considered [ 3 ]”
BackgroundSelf-citationDiagnosis and Management of Overlap Syndromes
Bunchorntavakul, C., & Reddy, K. R. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.09.005 · Cited by 44
“Although UDCA therapy alone may induce biochemical responses in some patients with AIH-PBC overlap,(26) most patients may require a combination of UDCA and immunosuppressive therapy to obtain a complete response.(24,38,39) In the”
BackgroundThe diagnosis of antimitochondrial antibody-negative primary biliary cholangitis
Özaslan, E., Efe, C., & ÖZASLAN, N. G. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.06.001 · Cited by 41
Role of Auto-Antibodies for the Diagnosis of Chronic Cholestatic Liver Diseases
Terjung, B., & Spengler, U. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:115 · Cited by 38
Dellavance, A., Júnior, A. G., Nuccitelli, B., Taliberti, B. H., von Mühlen, C. A., Bichara, C. D. A., dos Santos, C. H. R., Bueno, C., Yano, C. M., Mangueira, C. L. P., et al. (2009) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042009000200002 · Cited by 33
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis
Efe, C., Ozaslan, E., Heurgué-Berlot, A., Kav, T., Masi, C., Purnak, T., Torgutalp, M., Muratori, L., Bresson-Hadni, S., Thiéfin, G., et al. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000075 · Cited by 32
Metadata
- Authors
- Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Cologne (DE)
- Corresponding author
- Lohse, Ansgar W.
- Venue
- Hepatology
- Published
- 1999-04
- Volume
- 29
- Issue
- 4
- Pages
- 1078-1084
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2171662843
- Semantic Scholar
- aede3440eeab4134d81165c39316c389536598b6
- Cited by
- 278
- References
- 32
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 11 · 2016: 5 · 2015: 3 · 2014: 12 · 2013: 11 · 2012: 13
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 5997 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft, Bonn ((SFB 311))
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Keywords
- primary biliary cirrhosis, autoimmune hepatitis, overlap syndrome, antimitochondrial antibodies, HLA-DR3, HLA-DR4, HLA-B8, genetic susceptibility, bile duct destruction, immunosuppressive therapy
- MeSH terms
- Adolescent, Adult, Aged, Autoantibodies, Biopsy, Female, Follow-Up Studies, Histocompatibility Testing, Humans, Immunosuppressive Agents, Liver Cirrhosis, Biliary, Male, Middle Aged, Serologic Tests, Syndrome, Hepatitis, Autoimmune, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.